Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Minerva Surgical Inc

UTRS
Current price
0.0001 USD -0.012 USD (-99.17%)
Last closed 0.012 USD
ISIN US60343F1066
Sector Healthcare
Industry Medical Devices
Exchange PINK
Capitalization 106 542 USD
Yield for 12 month -100.00 %
1Y
3Y
5Y
10Y
15Y
UTRS
21.11.2021 - 28.11.2021

Minerva Surgical, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes minimally invasive solutions to meet the uterine healthcare needs of women in the United States. The company provides Minerva ES Endometrial Ablation System and Genesys HTA Endometrial Ablation System, which are endometrial ablation devices; Symphion Tissue Removal System, a minimally invasive uterine tissue removal system to combine bladeless tissue resection and coagulation, continuous visualization, and intrauterine pressure monitoring; and Resectr Tissue Resection Device, a handheld surgical instrument to enable the hysteroscopic removal and diagnosis of endometrial polyps. Its devices are utilized by obstetrician-gynecologists in various medical treatment settings, including hospitals, ambulatory surgical centers, and physician offices. The company was incorporated in 2008 and is headquartered in Santa Clara, California. Address: 4255 Burton Drive, Santa Clara, CA, United States, 95054

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

3 USD

P/E ratio

Dividend Yield

Current Year

+51 693 000 USD

Last Year

+50 294 000 USD

Current Quarter

+11 965 000 USD

Last Quarter

+13 391 000 USD

Current Year

+28 006 000 USD

Last Year

+27 242 000 USD

Current Quarter

+6 218 000 USD

Last Quarter

+7 402 000 USD

Key Figures UTRS

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -25 560 000 USD
Operating Margin TTM -50.95 %
PE Ratio
Return On Assets TTM -27.35 %
PEG Ratio
Return On Equity TTM -160.08 %
Wall Street Target Price 3 USD
Revenue TTM 51 693 000 USD
Book Value 2.28 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -4.9 %
Dividend Yield
Gross Profit TTM 27 242 000 USD
Earnings per share -7.61 USD
Diluted Eps TTM -7.61 USD
Most Recent Quarter III 2023
Quarterly Earnings Growth YOY
Profit Margin -64.71 %

Dividend Analytics UTRS

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History UTRS

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:20
Payout Ratio
Last Split Date 02.10.2023
Dividend Date

Stock Valuation UTRS

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 0.6293
Price Sales TTM 0.0021
Enterprise Value EBITDA -24.2143
Price Book MRQ 0.0053

Financials UTRS

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators UTRS

For 52 weeks

0.001 USD 3.49 USD
50 Day MA 0.012 USD
Shares Short Prior Month 7 635
200 Day MA 0.21 USD
Short Ratio 0.51
Shares Short 37 419
Short Percent 3.7 %